STANDALONE RESULTS FOR Q2 AND HALF YEAR ENDED 30.09.2025

Revenue Growth 20pctPat Growth 25pctExceptional ItemEbitda Margin CompressionResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.5%Reaction day

₹98.00

prior close

₹99.00

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.1%-0.6% vs market

Specialty Chemicals peers, median of 85sector+0.4%+0.1% vs sector

On the reaction day the stock moved 0.6 pts less than Nifty Microcap 250 and 0.1 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.1

10m

+1.1

15m

+0.1

30m

-7.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.5+1.1-0.6+0.4+0.1

Next day

-3.5+0.3-3.8-0.2-3.3

-7.2-1.4-5.8-1.4-5.7

-8.5-1.0-7.5-1.7-6.7

-9.4-1.4-8.0-2.0-7.4

-8.6-1.6-7.0-3.2-5.4

-7.5-0.8-6.7-2.9-4.6

15d

-0.3-3.6+3.3-7.9+7.6

+0.2-4.0+4.2-8.4+8.7

+4.2-3.9+8.1-8.1+12.3

+15.2-8.4+23.6-14.0+29.1

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 85Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Resonance Specialties, a Mumbai-based chemical manufacturer, posted Q2 FY26 revenue of Rs. 2,183.35 lakhs, up about 21% from Rs. 1,806.45 lakhs in Q2 FY25. Half-year revenue rose to Rs. 4,280.77 lakhs from Rs. 3,536.67 lakhs, a similar 21% YoY gain. Q2 profit after tax fell to Rs. 165.70 lakhs from Rs. 180.52 lakhs (down ~8%) due to higher conversion charges and depreciation-related costs, but half-year PAT jumped to Rs. 328.74 lakhs from Rs. 239.32 lakhs (~37% YoY). The results include an exceptional income of Rs. 11.88 lakhs in Q2 and Rs. 77.34 lakhs for the half year. EBITDA margins came under pressure in Q2 versus the year-ago quarter, indicating raw material and operating cost inflation. The auditor Kailash Chand Jain & Co. issued an unqualified limited review report with no qualifications or emphasis-of-matter paragraphs.

Likely market impact

Revenue growth is healthy and half-year PAT shows strong expansion, but the quarter-on-quarter margin squeeze and a Q2 PAT dip may draw investor attention. The clean auditor report and low debt levels (total borrowings of roughly Rs. 257 lakhs against equity of Rs. 6,612 lakhs) support financial stability, though cost-side discipline remains the key thing to watch.